Clinical trial Recruiting at 1 site Interventional Ages 65 to 75

EMG biofeedback to improve balance in older adults with osteoporosis

Official title: Effect of Biofeedback Activation on Balance in Osteoporotic Elderly Patients

Run by Cairo University · NCT07333989 · Data updated 2026-11-12

This will try EMG biofeedback of the gluteus medius combined with balance training to improve balance, muscle activation, physical performance, and quality of life in people aged 65–75 with osteoporosis.

More Elderly (People Aged 65 or More) trials

Quick facts

Study typeInterventional
Ages65 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Abū Ḩummuş)
StatusRecruiting
StartedJanuary 2, 2026
Main results expectedApril 5, 2026
Study endsMay 1, 2026
Registry record updatedMarch 20, 2026
Trial IDNCT07333989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 65–75 with osteoporosis confirmed by DEXA (T-score ≤ -2.5), a BMI of 25–29.9 kg/m², and intact cognition who can attend in-person training.

Probably not a fit

Patients with implanted electrical devices (such as pacemakers), active contagious skin conditions, significant cardiopulmonary or neuromuscular disease, or endocrine causes of metabolic bone disease are unlikely to be eligible or to receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, single-center study enrolls 60 adults aged 65–75 with osteoporosis (DEXA T-score ≤ -2.5) and BMI 25–29.9 to receive gluteus medius electromyography (EMG) biofeedback combined with structured balance training. The program is delivered in person and aims to increase gluteus medius activation during balance tasks. Outcomes include standardized balance measures, physical performance tests, EMG recordings of muscle activity, and quality-of-life assessments. Key exclusions include implanted electrical devices, active contagious skin conditions, cardiopulmonary or neuromuscular disorders, and endocrine causes of metabolic bone disease.

Why it matters

Potential benefit: If successful, the approach could improve balance and muscle control, reduce fall risk, and enhance quality of life for older adults with osteoporosis.

How similar studies have gone: Previous small trials using EMG biofeedback to enhance muscle activation and balance have shown promising but modest benefits, and this study applies that approach specifically to osteoporotic older adults.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients included in this study met the following criteria:

  1. Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
  2. Their age ranged between 65 - 75 years.
  3. Their BMI ranged between 25 - 29.9 kg/m2.
  4. They had good mentality and cognitive function.

Exclusion Criteria:

* The potential patients were excluded if they have one of the following criteria:

  1. Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
  2. Patients with active contagious skin conditions.
  3. Patients with implant devices such as pacemaker or electrical prosthesis.
  4. Any cardiopulmonary disorders.
  5. Any neuromuscular disorders.
  6. Any acute viral infection.
  7. Patients with ascites or end stage liver or kidney failure.
  8. Leg discrepancy.

Where it's running

  • General Hospital Abouhms
    Abū Ḩummuş, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.